0001179110-20-007720.txt : 20200623 0001179110-20-007720.hdr.sgml : 20200623 20200623161810 ACCESSION NUMBER: 0001179110-20-007720 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200619 FILED AS OF DATE: 20200623 DATE AS OF CHANGE: 20200623 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LYNCH DANIEL CENTRAL INDEX KEY: 0001177082 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37359 FILM NUMBER: 20982089 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Blueprint Medicines Corp CENTRAL INDEX KEY: 0001597264 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 45 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-374-7580 MAIL ADDRESS: STREET 1: 45 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml FORM 4 - X0306 4 2020-06-19 0 0001597264 Blueprint Medicines Corp BPMC 0001177082 LYNCH DANIEL C/O BLUEPRINT MEDICINES CORPORATION 45 SIDNEY STREET CAMBRIDGE MA 02139 1 0 0 0 Common Stock 2020-06-19 4 M 0 1312 A 125654 D Restricted Stock Units 2020-06-19 4 M 0 1312 0 D Common Stock 1312 0 D Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. On June 19, 2019, the reporting person was granted 1,312 restricted stock units. These restricted stock units are fully vested. /s/ Christopher Frankenfield, Attorney-in-Fact 2020-06-23